Wall Street Zen Downgrades Cigna Group (NYSE:CI) to Hold

Cigna Group (NYSE:CI) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday.

Several other research analysts have also recently weighed in on CI. Barclays cut shares of Cigna Group from an “overweight” rating to an “equal weight” rating and decreased their price target for the stock from $310.00 to $304.00 in a report on Tuesday, May 26th. Royal Bank Of Canada increased their target price on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Raymond James Financial set a $340.00 target price on Cigna Group in a research note on Friday, May 1st. Wells Fargo & Company increased their target price on Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. Finally, The Goldman Sachs Group increased their target price on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research note on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $338.30.

Cigna Group Trading Up 3.4%

Shares of CI stock opened at $290.17 on Friday. The company’s fifty day simple moving average is $279.58 and its two-hundred day simple moving average is $277.24. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The stock has a market capitalization of $76.76 billion, a price-to-earnings ratio of 12.30, a PEG ratio of 1.08 and a beta of 0.28.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts anticipate that Cigna Group will post 30.39 earnings per share for the current year.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by insiders.

Institutional Trading of Cigna Group

Institutional investors have recently added to or reduced their stakes in the business. DV Trading LLC boosted its holdings in shares of Cigna Group by 187.5% during the first quarter. DV Trading LLC now owns 920 shares of the health services provider’s stock worth $245,000 after purchasing an additional 600 shares during the period. Parallel Advisors LLC boosted its holdings in shares of Cigna Group by 26.1% during the first quarter. Parallel Advisors LLC now owns 3,568 shares of the health services provider’s stock worth $952,000 after purchasing an additional 738 shares during the period. NewEdge Advisors LLC boosted its holdings in shares of Cigna Group by 47.8% during the first quarter. NewEdge Advisors LLC now owns 34,277 shares of the health services provider’s stock worth $9,143,000 after purchasing an additional 11,085 shares during the period. Caerus Investment Advisors LLC purchased a new stake in shares of Cigna Group during the first quarter worth about $294,000. Finally, First Nebraska Trust Co purchased a new stake in shares of Cigna Group during the first quarter worth about $204,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.